What do soybean farmers and high-tech manufacturers have in common? More than you'd think-especially when it comes to economic dependence on China. While the stakes look different on the surface, both groups face mounting pressure from a supply chain dominated by a single, strategic global player.

For soybean producers, the story is familiar: China buys nearly 50% of all U.S. soybean exports, meaning any slowdown, tariff, or diplomatic chill can send shockwaves through farm income. That pain was felt sharply in recent years as Chinese purchases stalled, underscoring the fragility of relying too heavily on a single buyer.

Manufacturers, however, face the same kind of problem in reverse. Rather than selling to China, they rely on it for critical inputs and materials. A staggering 97% of global rare-earth minerals come from China-minerals essential for producing everything from smartphones and lasers to electric vehicles and military systems. It doesn't stop there. China also dominates the production of graphite, gallium, germanium, tungsten, magnesium, polysilicon, and other materials vital to advanced manufacturing.

Even U.S. pharmaceuticals are caught in this dependency web. Many active pharmaceutical ingredients-like those in acetaminophen, antibiotics, and blood pressure medications-are made in China or sourced from India, which itself relies on Chinese chemicals.

This supply chain vulnerability isn't accidental. It's the product of deliberate Chinese industrial policy, which uses tax breaks, subsidies, and tariff protection to help domestic firms outscale global competitors. In several cases, China has flooded markets to undercut Western producers, forcing them into collapse or selling off assets-sometimes to Chinese buyers.

The result? An industrial behemoth responsible for 35% of global manufacturing, with control not just of finished goods but of the upstream materials that fuel entire economies. Even basic semiconductors used in vehicles and consumer electronics are largely sourced from China.

U.S. administrations have taken notice. From Trump's high tariffs to Biden's CHIPS Act, Washington is attempting to revive domestic production and limit dependency. Companies, too, are reacting-reshoring manufacturing or shifting production to alternative countries. But scale remains China's trump card, making it difficult for any one country to compete alone.

Experts like Princeton's Aaron Friedberg argue that only collective action among allies-coordinated industrial policy and trade strategy-can address what some call the "second China shock." Yet current policies often alienate those same allies with sweeping tariffs, further complicating any unified approach.

Amid all this, soybean farmers might take a grim sort of comfort: their path forward is clearer. Diversifying export markets-a task already underway through efforts in Latin America, Southeast Asia, and beyond-could reduce exposure to Chinese volatility. But for manufacturers, rebuilding entire supply ecosystems could take years and enormous investment.

In the end, both sectors share the same strategic imperative: de-risk the China connection before the next shock hits.